Table 4.

Genes Overlapped by CNV Calls from at Least One Alzheimer’s Disease Participant and No Controls Using the Candidate Gene Approach.

Chromosome	Region	Start (bp)	End (bp)	Number of Alzheimer’s disease participants
1	CFH	194887630	194983257	1
6	ATXN1a	16407321	16869700	3
6	HLA-A	30018309	30021633	2
6	MICA	31479349	31491069	4
6	HLA-DQA1	32713160	32719407	5b
6	HLA-DOA	33079937	33085367	1c
6	HLA-DPB1a	33151737	33162954	1c
7	CD36	80069439	80146529	1
7	RELNa	102899472	103417198	1
9	APBA1	71235021	71477042	4
9	ABCA1	106583104	106730257	3
9	RXRA	136358230	136472252	1
10	ABCC2	101532452	101601652	1
11	PICALM	85346132	85457756	1
15	CYP19A1	49287545	49418087	1
15	CHRNA3	76674705	76700377	1
15	MEF2A	97956184	98071524	1
17	TP53	7512444	7531588	1
17	COX10	13913443	14052721	1
17	SREBF1	17656110	17681050	3b
17	CCL3	31439715	31441619	2
17	KIF18B	40358973	40380608	1
18	DSC1	26963211	26996817	1
21	NCAM2	21292503	21833085	1
21	APP	26174731	26465003	1
21	DOPEY2a	36458708	36588442	2
21	KCNJ6	37918656	38210566	2
22	COMT	18309308	18336530	2
22	BCR	21852551	21990224	1
22	GSTT1a	22706138	22714284	1

^aGenes also identified in the Alzheimer’s Disease Neuroimaging Initiative Study as being overlapped by CNV calls in Alzheimer’s disease and/or mild cognitive impairment participants, but not controls.

^bOne AD participant had CNV calls overlapping the two genes.

^cA different AD participant had CNV calls overlapping the two genes.